Takeda Pharmaceutical Company ( (TAK) ) has shared an update.
Takeda Pharmaceutical Company has submitted an extraordinary report detailing its decision to dissolve its specified subsidiary, Shire Pharmaceuticals International Unlimited Company, through liquidation. This move results in a significant change in the voting rights structure, marking the completion of a merger process where Takeda now holds no voting rights in the subsidiary. The liquidation process will follow local regulations, although the exact completion date is yet to be determined. This strategic decision reflects Takeda’s ongoing efforts to…
